Washington, D.C.-based REGENXBIO Inc., announced today that it had completed a $30 million Series C financing. The round was led by Enrick and Brookside Capital. Also participating were Deerfield Management and an unnamed new investor.
{iframe}http://www.biospace.com/News/with-30-million-regenxbio-to-finance-a-round-of/361733?source=sm&type=twitter_regenx01212015{/iframe}